ABSTRACT
Objective To investigate the clinical effect of three kinds of dose of pulmonary surfactant (PS) in neonatal respiratory distress syndrome (NRDS), and to determine the optimal dose. Methods One hundred and seventy-four cases of NRDS were divided into A group (59 cases), B group (57 cases) and C group (58 cases) according random digits table. Based on the conventional treatment, children in A group were given large dose of poractant alfa injection 250 mg/kg, children in B group were given 200 mg/kg, and children in C group were given 100 mg/kg. After treatment for 1, 6, 12 and 24 h, the arterial oxygen saturation (SaO2), inspired oxygen concentration (FiO2), arterial oxygen tension (PaO2), oxygenation index (OI), arterial/alveolar oxygen tension ratio (a/APO 2), ventilator using and oxygen using time and the incidence of complication were compared. Results After treatment for 12,and 24 h, the levels of SaO 2 in A group and B group were significantly higher than those in C group: 0.936 ± 0.018, 0.935 ±0.019 vs. 0.857 ±0.027;0.941 ±0.017, 0.946 ±0.015 vs. 0.847 ±0.053, and there were significant differences (P0.05). After treatment for 1, 6, 12, and 24 h, the levels of FiO 2 and OI in A group and B group were significantly lower than those in C group, and the levels of PaO 2 and a/APO2 in A group and B group were significantly higher than those in C group. There were significant differences (P0.05). The ventilator using time in A, B and C group were (108.6±23.5) , (119.6±32.8), (156.3±27.3) h, and there were significant differences (P0.05). The oxygen using time in C group was significantly longer than that in A and B group: (186.5 ± 52.8) h vs. (148.7 ±24.4), (154.6±28.2), P0.05).The incidence of complication in C group was significantly higher than that in A and B group:29.31%(17/58) vs. 13.56%(8/59), 12.28%(7/57), P<0.05. Conclusions Poractant alfa injection 200 mg/kg is optimal dosage for poractant alfa injection in the treatment of NRDS, and it can effectively improve oxygenation and ventilation function, reduce the incidence of complication, shorten the course of disease and improve the prognosis and increase the cure rate. Excessive dose is waste, and little dose can not get effective treatment.
ABSTRACT
Objective To observe effect of using ambroxol to humidify of airway during mechanical ventilation to treat severe pneumonia in infants,and to explore dynamic changes of respiratory mechanics.Methods Sixty-five infants with severe pneumonia need ventilator treatment according the diagnosis criterion were divided into 2 groups by random digits table method:experimental group (33 cases) and control group (32 cases).Experimental group was used ambroxol and control group was used 0.9％ sodium chloride,each 2 ml intratracheal instillation,and then took the balloon pressurized oxygen 30 s,followed by ventilator,after 24 h.Changes of respiratory mechanics indexes were observed before and after treatment,including:mean airway resistance,lung dynamic compliance,work of breathing,airway plateau pressure.Respiratory mechanics values were recorded before and after treatment.Results After treatment for 24 h,the index in experimental group were better than those in control group.Mean airway resistance were (0.68 ± 0.04) cmH2O/ (L·s) and (0.57 ± 0.05) cmH2O/ (L·s),1 cmH2O =0.098 kPa,lung dynamic compliance were (3.17 ± 0.81) ml/kPa and (2.56 ± 0.69) ml/kPa,work of breathing were (0.54 ± 0.08) J/L and(0.41 ± 0.06) J/L,airway plateau pressure were (2.23 ± 0.58) cmH2O and (2.12 ± 0.63) cmH2O.There were significant differences (P ＜ 0.05).The mechanical ventilation time in experimental group was significantly shorter than that in control group [(64.08 ± 13.92) h vs.(79.57 ± 19.64) h] (P ＜0.05).Conclusion Airway humidification using ambroxol can better treat severe pneumonia,reduce airway resistance and improve alveolar ventilation,shorten time on the machine.
ABSTRACT
@#Objective To observe the effect of buspirone on ataxia symptom after stroke.Methods 30 patients with ataxia after stroke were treated with buspirone,other 30 patients without buspirone as controls.Before and after treatment,they were assessed with ataxia-scale.Results The buspirone can significantly improve the ataxia of patients with stroke compared with the controls(P<0.01).Conclusion Short-term treatment with buspirone can improve the ataxia symtoms after stroke.
ABSTRACT
<p><b>BACKGROUND</b>It has been known that an intensive relationship exists between the recurrence or metastasis and angiogenesis and lymphangiogenesis in patients with non-small cell lung cancer (NSCLC), but it is uncertain whether there is relationship between VEGF-C expression and angiogenesis and lymphangiogenesis in NSCLC tissues. This study is to explore the relationship among VEGF-C expression and angiogenesis and lymphangiogenesis and lymphatic metastasis in NSCLC tissues.</p><p><b>METHODS</b>The expression of VEGF-C was detected in 78 lung cancer tissues with or without lymphatic metastasis by LSAB methods. Microvessel density (MVD) and lymphatic microvessel density (LMVD) were determined in the same patients by CD31 and VEGFR-3 respectively.</p><p><b>RESULTS</b>The positive rate of VEGF-C expression was 52.6% (41/78) in NSCLC tissues; VEGF-C expression in lung cancer tissues with lymphatic metastasis (30/43, 69.7%) was significantly higher than that without lymphatic metastasis (11/35, 30.3%) (P < 0.05); LMVD in the group without VEGF-C expression (23.4±2.3) was significantly lower than that with VEGF-C expression (43.2±4.1) (P < 0.05), there was no singificant difference in MVD between the two groups (31.1±1.8 vs 28.1± 3.2) (P > 0.05); the MVD and LMVD in lung cancer tissues with lymphatic metastasis (33.6±1.1 and 41.3±3.3 respectively) were significantly higher than those without lymphatic metastasis (18.7±1.8 and 25.7± 2.1 respectively) (P < 0 05).</p><p><b>CONCLUSIONS</b>The results suggest that VEGF-C may play an important role in the lymphatic metastasis of lung cancer through the regulation of lymphangiogenesis.</p>